BibTex RIS Cite

Development of diabetes in a patient with hypertriglyceridemia-induced necrotizing pancreatitis

Year 2013, , 238 - 241, 01.09.2013
https://doi.org/10.5505/abantmedj.2013.60783

Abstract

Acute necrotizing pancreatitis is a form of pancreatitis which has a high rate of morbidity and mortality. Medical and surgical approaches are diffrent therapautic choices that can be based on the clinical situation. The common causes of pancreatitis are chronic alcohol use and biliary pathologies. Hypertriglyceridemia induced acute pancreatitis is rarely encountered in clinics. In this report we present a case with diabetes mellitus resulted after hypertriglyceridemia induced acute pancreatitis and pancreatic failure.

References

  • Burdick JS, Tompwson ML. Pancreas In: Feldman M, Friadmen L, Brandt L, Sliesenger M. Gastrointestinal and Liver Disease. 8th ed. Saunders Elsevier, 2006, p. 1174-84.
  • Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996; 20: 177-184.
  • Thompson GR. Primary hyperlipidaemia. Br Med Bull. 1990; 46(4): 986-1004.
  • Dominguez-Muñoz JE, Malfertheiner P, Ditschuneit HH, Blanco-Chavez J, Uhl W, Büchler M, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol. 1991; 10(3-4): 261- 7.
  • Yetim I, Ozkan OV, Diner G, Yılmaz A, Gokce C, Kaya H. Necrotizing development result:A cese port. J Clin Anal Med 2011;2(3):124-6.
  • Fortson MR, Freedman SR, Webster PD 3rd. Clinical assesment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90(12): 2134.
  • Yeh JH, Chen JH, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J Clin Apheresis. 2003; (18)4: 181-5.
  • C. Stefanutti, S. Di Giacomo, A. Vivenzio et al., “Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study,” Artificial Organs, vol. 33, no. 12, pp.1096–1102, 2009.
  • Z. M. Szczepiorkowski, N. Bandarenko, H. C. Kim et al.,“Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis,” Journal of Clinical Apheresis, vol. 22, no. 3, pp. 106–175, 2007.
  • Yoon YK, Ji JH, Mun BS. Hypertriglyceridemia-induced pancreatitis .Korean J Gastroenterol. 2008 May;51(5):309- 13.
  • Branum G, Galloway J, Hirchowitz W, Fendley M, Hunter J. Pancreatic necrosis: results of necrosectomy, packing, and ultimate closure over drains. Ann Surg 1998;227:870-7.
  • Türk Endokrinoloji ve Metabolizma Hastalıkları Derneği. Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu-2011.
  • Wang W, Guo Y, Liao Z, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011; 40(2):206–12.

Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi

Year 2013, , 238 - 241, 01.09.2013
https://doi.org/10.5505/abantmedj.2013.60783

Abstract

Akut nekrotizan pankreatit mortalite ve morbidite oranı yüksek bir pankreatit formudur. Tedavisi klinik duruma göre medikal ve cerrahi olabilmektedir. Pankreatitin en sık nedeni kronik alkol kullanımı ve bilier patolojilerdir. Hipertrigliseridemiden kaynaklanan akut pankreatitler daha nadirdir. Bu yazıda hipertrigliseridemi sonucu akut yaygın nekrotizan pankreatit ve sonrasında pankreatik yetmezlik sonucu diyabetes mellitus DM gelişen 37 yaşındaki erkek hasta literatür eşliğinde tartışılmıştır.

References

  • Burdick JS, Tompwson ML. Pancreas In: Feldman M, Friadmen L, Brandt L, Sliesenger M. Gastrointestinal and Liver Disease. 8th ed. Saunders Elsevier, 2006, p. 1174-84.
  • Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996; 20: 177-184.
  • Thompson GR. Primary hyperlipidaemia. Br Med Bull. 1990; 46(4): 986-1004.
  • Dominguez-Muñoz JE, Malfertheiner P, Ditschuneit HH, Blanco-Chavez J, Uhl W, Büchler M, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol. 1991; 10(3-4): 261- 7.
  • Yetim I, Ozkan OV, Diner G, Yılmaz A, Gokce C, Kaya H. Necrotizing development result:A cese port. J Clin Anal Med 2011;2(3):124-6.
  • Fortson MR, Freedman SR, Webster PD 3rd. Clinical assesment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90(12): 2134.
  • Yeh JH, Chen JH, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J Clin Apheresis. 2003; (18)4: 181-5.
  • C. Stefanutti, S. Di Giacomo, A. Vivenzio et al., “Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study,” Artificial Organs, vol. 33, no. 12, pp.1096–1102, 2009.
  • Z. M. Szczepiorkowski, N. Bandarenko, H. C. Kim et al.,“Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis,” Journal of Clinical Apheresis, vol. 22, no. 3, pp. 106–175, 2007.
  • Yoon YK, Ji JH, Mun BS. Hypertriglyceridemia-induced pancreatitis .Korean J Gastroenterol. 2008 May;51(5):309- 13.
  • Branum G, Galloway J, Hirchowitz W, Fendley M, Hunter J. Pancreatic necrosis: results of necrosectomy, packing, and ultimate closure over drains. Ann Surg 1998;227:870-7.
  • Türk Endokrinoloji ve Metabolizma Hastalıkları Derneği. Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu-2011.
  • Wang W, Guo Y, Liao Z, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011; 40(2):206–12.
There are 13 citations in total.

Details

Primary Language Turkish
Journal Section Case Report
Authors

Hacer Şen This is me

Emine Binnetoğlu This is me

Fahri Güneş This is me

Mehmet Aşık This is me

Betül Kızıldağ This is me

Şengül Özçelik This is me

Kubilay Ukinc This is me

Publication Date September 1, 2013
Published in Issue Year 2013

Cite

APA Şen, H., Binnetoğlu, E., Güneş, F., Aşık, M., et al. (2013). Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi. Abant Medical Journal, 2(3), 238-241. https://doi.org/10.5505/abantmedj.2013.60783
AMA Şen H, Binnetoğlu E, Güneş F, Aşık M, Kızıldağ B, Özçelik Ş, Ukinc K. Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi. Abant Med J. September 2013;2(3):238-241. doi:10.5505/abantmedj.2013.60783
Chicago Şen, Hacer, Emine Binnetoğlu, Fahri Güneş, Mehmet Aşık, Betül Kızıldağ, Şengül Özçelik, and Kubilay Ukinc. “Hipertrigliseridemi Sonucu oluşan Nekrotizan Pankreatit Olgusunda Diyabet gelişimi”. Abant Medical Journal 2, no. 3 (September 2013): 238-41. https://doi.org/10.5505/abantmedj.2013.60783.
EndNote Şen H, Binnetoğlu E, Güneş F, Aşık M, Kızıldağ B, Özçelik Ş, Ukinc K (September 1, 2013) Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi. Abant Medical Journal 2 3 238–241.
IEEE H. Şen, E. Binnetoğlu, F. Güneş, M. Aşık, B. Kızıldağ, Ş. Özçelik, and K. Ukinc, “Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi”, Abant Med J, vol. 2, no. 3, pp. 238–241, 2013, doi: 10.5505/abantmedj.2013.60783.
ISNAD Şen, Hacer et al. “Hipertrigliseridemi Sonucu oluşan Nekrotizan Pankreatit Olgusunda Diyabet gelişimi”. Abant Medical Journal 2/3 (September 2013), 238-241. https://doi.org/10.5505/abantmedj.2013.60783.
JAMA Şen H, Binnetoğlu E, Güneş F, Aşık M, Kızıldağ B, Özçelik Ş, Ukinc K. Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi. Abant Med J. 2013;2:238–241.
MLA Şen, Hacer et al. “Hipertrigliseridemi Sonucu oluşan Nekrotizan Pankreatit Olgusunda Diyabet gelişimi”. Abant Medical Journal, vol. 2, no. 3, 2013, pp. 238-41, doi:10.5505/abantmedj.2013.60783.
Vancouver Şen H, Binnetoğlu E, Güneş F, Aşık M, Kızıldağ B, Özçelik Ş, Ukinc K. Hipertrigliseridemi sonucu oluşan nekrotizan pankreatit olgusunda diyabet gelişimi. Abant Med J. 2013;2(3):238-41.